Yahoo4h
Dr. Todd Ellerin on the effects of popular weight-loss drug Wegovy
Dr. Todd Ellerin, Vice Chair of Medicine at South Shore Health, talks to WCVB's Ed Harding about the effects popular ...
CBS19 News6h
Virginia Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
KSJB AM8h
U.S. Obesity Market Analysis: Exploring Demographic & Geographic Disparities in GLP-1 Use
As demand for Wegovy quickly outpaced supply, other industry competitors began to jump into the obesity market. This trend ...
The Manhattan Mercury9h
Kansas Residents Are Using GLP-1s at an Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
The Digital Courier9h
North Carolina Residents Are Using GLP-1s at a Slightly Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Iosco County News-Herald9h
Michigan Residents Are Using GLP-1s at the 6th Highest Rate in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Southwest Iowa News9h
Iowa Has the 9th Highest Rate of GLP-1 Use in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
ConsumerAffairs9h
Diabetes Cure
If you said diabetes, you're right -- a new study finds diabetes costs $101 billion annually in diagnosis and treatment and ...
Stoneham Independent10h
Massachusetts Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
KTEN1d
Texas Has the 10th Lowest Rate of GLP-1 Use in the Nation
As demand for Wegovy quickly outpaced supply, other industry competitors began to jump into the obesity market. This trend ...
TiogaPublishing.com1d
Pennsylvania Residents Are Using GLP-1s at the 10th Highest Rate in the Country
As demand for Wegovy quickly outpaced supply, other industry competitors began to jump into the obesity market. This trend ...
San Francisco Examiner1d
California Residents Are Using GLP-1s at the 11th Lowest Rate in the Country
Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound) work by ...